KP Rx
KP Rx is a venture capital firm in Sydney, Australia, investing at Early Stage in Australasia backing healthcare companies. It has an estimated $94.3M in dry powder and a cheque size of $1.3M–$6.5M. Its latest deal was Navi Medical Technologies Pty Ltd (Jul 2026).
See if KP Rx fits your roundIs your startup a good fit for KP Rx?
Est. dry powder
$94.3M
Raised, not yet invested
AUM
—
Not reported
Latest fund
$130.7M
KP Rx Healthcare Opportunities Fund
Est. cheque size
$1.3M–
From fund sizes
Deals, last 12 months
1
Last seen investing Jul 2026
About KP Rx
KP RX is a venture capital firm that invests in early-stage healthcare investments, spanning biotech, medical devices, diagnostics and health tech verticals across Australia and New Zealand.
- Type
- Venture Capital Firm
- Headquarters
- Sydney, New South Wales, Australia
- Stages
- Early Stage
- Est. cheque size
- $1.3M–$6.5M
- Sectors
- Healthcare
- Regions
- Australasia
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
Not enough data
Across 1 deals
Portfolio sectors
- Medical Devices & Equipment1
Across 1 companies
Portfolio countries
- Australia1
Across 1 companies
Recent investments
Newest 1 of 1
- Unspecified Round$4.7M
Navi Medical Technologies Pty Ltd
Jul 2026 · Unspecified Round
Offices
1 location
- Sydney, New South Wales, AustraliaHQ
Questions about KP Rx
What type of firm is KP Rx?
KP Rx is a venture capital firm, founded in 2023.
Is KP Rx actively investing?
Yes. KP Rx made 1 investment in the last 12 months, most recently Navi Medical Technologies Pty Ltd in Jul 2026.
How much does KP Rx invest per deal?
Based on the size of its funds, KP Rx writes estimated cheques of $1.3M–$6.5M. Lead cheques usually sit at the top of that range and follow-on cheques lower.